| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |